Genome-wide analysis for non alcoholic fatty liver disease

Genome-wide association study for the 902 patients of non alcoholic fatty liver disease (NAFLD) including non alcoholic steato hepatitis (NASH) and hepatocellurar carcinoma and 7672 controls.

• Type: Case-Control
• Archiver: Japanese Genotype-phenotype Archive (JGA)